Clinical Trials Directory

Trials / Recruiting

RecruitingNCT01745237

Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis

Detection and Prognostic Significance of Myocardial Damage Visualized by Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis

Status
Recruiting
Phase
Study type
Observational
Enrollment
27,000 (estimated)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study was to determine the ability of cardiac magnetic resonance (CMR) to identify cardiac involvement in patients with sarcoidosis. Patients were to undergo CMR in addition to routine clinical evaluation.

Detailed description

In patients with sarcoidosis, cardiac death is a leading cause of mortality which may represent unrecognized cardiac involvement. Cardiovascular magnetic resonance (CMR) can detect cardiac involvement including minute amounts of myocardial damage. Therefore, the objective of this study was to determine the usefulness of CMR and compare it with standard clinical evaluation for cardiac involvement. Patients with documented extracardiac sarcoidosis or clinically suspected cardiac sarcoidosis will be enrolled.

Conditions

Timeline

Start date
2002-09-01
Primary completion
2032-06-01
Completion
2032-06-01
First posted
2012-12-10
Last updated
2025-04-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01745237. Inclusion in this directory is not an endorsement.